|
ABHD13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.87361279005927E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54319998393981E-09 |
| Normal-vs-Stage2 |
3.36159999947405E-07 |
| Normal-vs-Stage3 |
3.64479557646291E-11 |
| Normal-vs-Stage4 |
3.77764486358956E-12 |
| Stage1-vs-Stage2 |
3.824600E-01 |
| Stage1-vs-Stage3 |
6.520200E-02 |
| Stage1-vs-Stage4 |
1.421010E-03 |
| Stage2-vs-Stage3 |
6.657600E-01 |
| Stage2-vs-Stage4 |
1.495650E-01 |
| Stage3-vs-Stage4 |
2.084200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49460452295125E-11 |
| Normal-vs-AfricanAmerican |
4.555500E-04 |
| Normal-vs-Asian |
9.69360000047104E-08 |
| Caucasian-vs-AfricanAmerican |
4.978200E-01 |
| Caucasian-vs-Asian |
8.022600E-01 |
| AfricanAmerican-vs-Asian |
4.443800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38355993328787E-12 |
| Normal-vs-Female |
2.7083002507311E-10 |
| Male-vs-Female |
3.608000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47850000020711E-07 |
| Normal-vs-Age(41-60Yrs) |
4.98723284891867E-12 |
| Normal-vs-Age(61-80Yrs) |
1.65859548317826E-11 |
| Normal-vs-Age(81-100Yrs) |
1.392330E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.742100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.159000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.790400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.023400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.474000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.941600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.722500E-02 |
| Classical-VS-Follicular |
5.321500E-03 |
| Classical-VS-Other |
2.937600E-01 |
| Classical-VS-Normal |
9.52169998402752E-09 |
| Tall-VS-Follicular |
8.589600E-01 |
| Tall-VS-Other |
8.087200E-01 |
| Tall-VS-Normal |
5.14559994613251E-09 |
| Follicular-VS-Other |
9.080600E-01 |
| Follicular-VS-Normal |
7.77390374295805E-11 |
| Other-VS-Normal |
1.683220E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.24780219279819E-12 |
| Normal-vs-N1 |
1.62350022314683E-10 |
| N0-vs-N1 |
2.575400E-01 |
|
|
